Revankar Shriram sold $188K of DLB

Revankar Shriram (SVP, Advanced Technology Group) sold 3,000 shares of Dolby Laboratories, Inc. (DLB) at $62.71 ($0.19M total) on 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Revankar Shriram
Published Aug 18, 2026, 9:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 10:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DLB
Neutral
high confidence
Mentioned
$DLB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

The only new fact is the disclosed sale size, price, and post-transaction holdings; it does not include any guidance, deal, or regulatory development.

02

Market read

Traders may note the insider sale, but the 10b5-1 designation makes it more consistent with routine selling than a fundamental catalyst.

03

What to watch

The article does not state whether the sale was part of a scheduled diversification or tax-related liquidity need, so interpretation should be cautious.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed Aug. 18 for an Aug. 14 sale.

Background

The article reports an SEC Form 4 insider transaction for Dolby Laboratories, Inc. (DLB) by SVP Revankar Shriram.

Company-level read

Ticker impact

$DLBNeutralHigh confidence
Context

Dolby Laboratories SVP Revankar Shriram sold 3,000 shares at $62.71 under a pre-arranged 10b5-1 plan, per Form 4 filed Aug. 18.

Expected impact

Low likelihood of a sustained price move from this filing alone; any reaction is likely muted and short-lived.

Evidence & confidence

The disclosure is an open-market sale by an officer, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company-specific operational or financial information.

Market effects

Minimal, as the filing does not indicate sector-wide regulatory, product, or demand changes.

None indicated.

None indicated.

Counterpoint

Insider sales can sometimes coincide with private information, but the presence of a 10b5-1 plan reduces that inference.

Key entities

  • Dolby Laboratories, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Revankar Shriram

    SVP, Advanced Technology Group who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAMedAI 8/10

Futures Rise As Huang-less Nvidia Beats And Raises, Gold Crashes Below $3,800

US futures rise as Nvidia (NVDA) reports strong earnings and raises guidance, boosting AI-related stocks. Gold drops below $3,800 after Fed Governor Waller's comments. Nvidia's Q4 revenue guidance is $130B vs. estimates of $125B. Premarket movers include TSLA, GOOGL, AMZN, AAPL, META, AVGO, CRWV, AAOI, BLSH, DLB, LOW, SLS, TTWO, TNDM. Fed policy and economic data releases are in focus.

$DLBMed

Dolby Laboratories Q4 Earnings Call Highlights

Dolby Laboratories reported Q4 earnings with Atmos, Vision, and imaging patents revenue growing 18%, surpassing foundational audio. The company expects mid-single-digit declines in foundational audio and similar growth in other segments for fiscal 2027. New CEO Kevin Whitten focuses on AI and recurring revenue. Dolby anticipates Q1 revenue of $285M-$305M and full-year non-GAAP operating expenses of $775M. The company has $713M in cash and no debt, repurchasing $265M in shares in fiscal 2026.

$DLBMedAI 9/10

Dolby Laboratories Profit Advances In Q4

Dolby Laboratories (DLB) reported Q4 earnings of $80.9M ($0.86 per share), up from $49.3M ($0.51 per share) last year. Adjusted earnings were $117.8M ($1.25 per share). Revenue increased 21.7% to $373.5M. The company guided next quarter's EPS to $0.41-$0.56 and revenue to $285M-$305M.